Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

A decision model for the watch-and-wait strategy in systemic sclerosis-associated interstitial lung disease (SSc-ILD).

pf treatments

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 10 July 2015 - 07:36 AM

A decision model for the watch-and-wait strategy in systemic sclerosis-associated interstitial lung disease (SSc-ILD).

 

Watchful waiting may be effective for SSc-ILD patients who have minimal pulmonary involvement on CT and lack pulmonary arterial hypertension on echocardiography at baseline. PubMed, Rheumatology (Oxford), 05/13/2015. (Also see Pulmonary Fibrosis Treatments)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)






Also tagged with one or more of these keywords: pf treatments